相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nuclear Receptors as Modulators of the Tumor Microenvironment
Mara H. Sherman et al.
CANCER PREVENTION RESEARCH (2012)
Current Concepts and Management of Glioblastoma
Matthias Preusser et al.
ANNALS OF NEUROLOGY (2011)
Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer
Denis Drygin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Integrin αβ1, αvβ, α6β effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance
Hope A. Sansing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells
Hyung-Ok Lee et al.
BMC CANCER (2011)
Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
Nicholas Robert et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
Klaus Podar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
Marek Mraz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Chemotherapeutic Resistance: Surviving Stressful Situations
Luke A. Gilbert et al.
CANCER RESEARCH (2011)
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi et al.
CANCER RESEARCH (2011)
Cancer Stem Cell Niche: The Place to Be
Tijana Borovski et al.
CANCER RESEARCH (2011)
Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis
Jacky G. Goetz et al.
CELL (2011)
Epithelial cell polarity: a major gatekeeper against cancer?
C. Royer et al.
CELL DEATH AND DIFFERENTIATION (2011)
β1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence
Dalit Barkan et al.
CLINICAL CANCER RESEARCH (2011)
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Jermaine Coward et al.
CLINICAL CANCER RESEARCH (2011)
Framework models of tumor dormancy from patient-derived observations
Christoph A. Klein
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Markus F. Neurath et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
Saima Hassan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
NF-κB Protects Cells from Gamma Interferon-Induced RIP1-Dependent Necroptosis
Roshan J. Thapa et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Bortezomib: Understanding the Mechanism of Action
Bilal Piperdi et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment
Jayme B. Stokes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance
Edward H. Flach et al.
MOLECULAR PHARMACEUTICS (2011)
Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma
R. R. Singh et al.
ONCOGENE (2011)
Carcinoma Matrix Controls Resistance to Cisplatin through Talin Regulation of NF-kB
Karen E. Eberle et al.
PLOS ONE (2011)
Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma
Vivekanand Gupta et al.
PLOS ONE (2011)
Differential Expressions of Adhesive Molecules and Proteases Define Mechanisms of Ovarian Tumor Cell Matrix Penetration/Invasion
Youngjoo Kwon et al.
PLOS ONE (2011)
A Peptide of SPARC Interferes with the Interaction between Caspase8 and Bcl2 to Resensitize Chemoresistant Tumors and Enhance Their Regression In Vivo
Mahbuba Rahman et al.
PLOS ONE (2011)
Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review
Alberto J Montero et al.
Expert Review of Clinical Pharmacology (2011)
Lymph Node Stromal Cells Enhance Drug-Resistant Colon Cancer Cell Tumor Formation through SDF-1α/CXCR4 Paracrine Signaling
David A. Margolin et al.
NEOPLASIA (2011)
Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases
Lisa D. Volk et al.
NEOPLASIA (2011)
Natalizumab and Progressive Multifocal Leukoencephalopathy
Clemens Warnke et al.
ARCHIVES OF NEUROLOGY (2010)
The benefits and challenges associated with the use of drug delivery systems in cancer therapy
Edna Cukierman et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Involvement of tumor necrosis factor-α in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori
Chenghai Zhao et al.
BMC CANCER (2010)
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment
Britta Weigelt et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
A Randomized Phase 2 Study of Etaracizumab, a Monoclonal Antibody Against Integrin αvβ3, ± Dacarbazine in Patients With Stage IV Metastatic Melanoma
Peter Hersey et al.
CANCER (2010)
The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
Kirsten Hattermann et al.
CANCER RESEARCH (2010)
Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin α5β1 and Fibronectin
Jin-Min Nam et al.
CANCER RESEARCH (2010)
Disruption of Laminin-Integrin-CD151-Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists
Xiuwei H. Yang et al.
CANCER RESEARCH (2010)
The NF-kappa B activation pathways, emerging molecular targets for cancer prevention and therapy
Yong Lin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Targeting Notch signaling in pancreatic cancer
Elodie Ristorcelli et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
The extracellular matrix at a glance
Christian Frantz et al.
JOURNAL OF CELL SCIENCE (2010)
Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway
Yasuhiro Kidera et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Integrins as therapeutic targets: lessons and opportunities
Dermot Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity
D. Basu et al.
ONCOGENE (2010)
Adhesion molecules-The lifelines of multiple myeloma cells
Ben-Zion Katz
SEMINARS IN CANCER BIOLOGY (2010)
Does tumour dormancy offer a therapeutic target?
Paul E. Goss et al.
NATURE REVIEWS CANCER (2010)
nab-paclitaxel: a novel formulation of taxane for treatment of breast cancer
Prakash Vishnu et al.
WOMENS HEALTH (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma
Abdel Kareem Azab et al.
BLOOD (2009)
Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta I-integrins
Remedios Castello-Cros et al.
BMC CANCER (2009)
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
R. Marechal et al.
BRITISH JOURNAL OF CANCER (2009)
β1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation
Kenneth H. Shain et al.
CANCER RESEARCH (2009)
CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival
Antonella Zucchetto et al.
CANCER RESEARCH (2009)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3-Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma
Guido Bisping et al.
CLINICAL CANCER RESEARCH (2009)
Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Wei Wang et al.
CLINICAL CANCER RESEARCH (2009)
Chemokine Receptors as Targets for Cancer Therapy
Xuesong Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Biological Therapies for Inflammatory Bowel Diseases
Paul Rutgeerts et al.
GASTROENTEROLOGY (2009)
Epigenetic Inheritance and the Missing Heritability Problem
Montgomery Slatkin
GENETICS (2009)
CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Antithrombotics in Acute Coronary Syndromes
Marc P. Bonaca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
D. R. Shepard et al.
JOURNAL OF UROLOGY (2009)
Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.
Charles M. Rudin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
K. Noborio-Hatano et al.
ONCOGENE (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J. Borowitz et al.
BLOOD (2008)
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma
Tine S. Mantoni et al.
CANCER BIOLOGY & THERAPY (2008)
β1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts
Catherine C. Park et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Mert Erkan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner
Roderick M. Quiros et al.
GYNECOLOGIC ONCOLOGY (2008)
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
S. Tavor et al.
LEUKEMIA (2008)
Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells
Ilya Serebriiskii et al.
MATRIX BIOLOGY (2008)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesus F. San Miguel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies
M. Mimeault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors
Catherine Delbaldo et al.
INVESTIGATIONAL NEW DRUGS (2008)
Integrins in angiogenesis and lymphangiogenesis
Christie J. Avraamides et al.
NATURE REVIEWS CANCER (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Overexpression of integrin β1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing Skp2-dependent degradation of p27 via PI3K pathway
Yi Fu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas
Tint Lwin et al.
BLOOD (2007)
Modeling tissue morphogenesis and cancer in 3D
Kenneth M. Yamada et al.
CELL (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Natalizumab for multiple sclerosis
Richard M. Ransohoff
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Simvastatin inactivates β1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells
Ikuko Takeda et al.
CANCER SCIENCE (2007)
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
J. Juarez et al.
LEUKEMIA (2007)
Ligand Bound β1 Integrins Inhibit Procaspase-8 for Mediating Cell Adhesion-Mediated Drug and Radiation Resistance in Human Leukemia Cells
Doris Estrugo et al.
PLOS ONE (2007)
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo
Lihua Yang et al.
CANCER RESEARCH (2007)
beta 1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells
L. A. Hazlehurst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis
M. Z. Ratajczak et al.
LEUKEMIA (2006)
The matrix reorganized: extracellular matrix remodeling and integrin signaling
Melinda Larsen et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase
P. S. Hodkinson et al.
CELL DEATH AND DIFFERENTIATION (2006)
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
Anthony D. Yang et al.
CLINICAL CANCER RESEARCH (2006)
Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression
DA Beacham et al.
SEMINARS IN CANCER BIOLOGY (2005)
Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts
MD Amatangelo et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling
A Spiegel et al.
BLOOD (2004)
Integrins: roles in cancer development and as treatment targets
H Jin et al.
BRITISH JOURNAL OF CANCER (2004)
The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase
R Schmidmaier et al.
BLOOD (2004)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death
LA Hazlehurst et al.
ONCOGENE (2003)
Ras GTPases: Integrins' friends or foes?
K Kinbara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
T Matsunaga et al.
NATURE MEDICINE (2003)
Dimensions and dynamics in integrin function
KM Yamada et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2003)
Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms
Y Nefedova et al.
LEUKEMIA (2003)
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma
G Bisping et al.
BLOOD (2003)
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
CA Sherman-Baust et al.
CANCER CELL (2003)
Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
C Denoyelle et al.
CELLULAR SIGNALLING (2003)
Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis
CD Capo-Chichi et al.
CANCER (2002)
The protein kinase B/Akt signalling pathway in human malignancy
KM Nicholson et al.
CELLULAR SIGNALLING (2002)
Role of integrins in cell invasion and migration
JD Hood et al.
NATURE REVIEWS CANCER (2002)
Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines
KH Shain et al.
JOURNAL OF IMMUNOLOGY (2002)
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
D Gupta et al.
LEUKEMIA (2001)
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells
F Aoudjit et al.
ONCOGENE (2001)
VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells
CD Weekes et al.
LEUKEMIA & LYMPHOMA (2001)
Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)
LA Hazlehurst et al.
ONCOGENE (2000)
Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1
P Henriet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
K Nakayama et al.
EMBO JOURNAL (2000)
Epigenetic determinants of resistance to etoposide regulation of Bcl-xL and Bax by tumor microenvironmental factors
ST Taylor et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
